SavedAdd your journal

Journals / EMU Journal of Pharmaceutical Sciences / 2026 / Volume: 9 Issue: 2

Coumarin-Piperazine Hybrids: An Investigation of Molecular Structure and Biological Activity (A Mini Review)

Özge Özükanar(İSTANBUL TEKNİK ÜNİVERSİTESİ)0000-0003-0430-8136
Pages
—
Publication Date
2026-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, coumarin-piperazine hybrids have emerged as one of the most notable hybrid systems in modern drug design due to their structural diversity and ability to interact with multiple biological targets.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this review, the effects of coumarin-piperazine hybrids on various biological targets are evaluated in light of current literature data (2013-2026).
📊
Key Findings & Data:Coumarin-piperazine hybrids have been demonstrated to possess a wide range of pharmacological potential, including antibacterial, antimicrobial, antimalarial, antiviral, anticancer, antidiabetic, anti-Alzheimer's, and antitumor activities.
💡
Conclusion & Impact:Overall, coumarin-piperazine hybrids have emerged as one of the most notable hybrid systems in modern drug design due to their structural diversity and ability to interact with multiple biological targets.
🔬Design:Review & Systematic Survey
📍Scope:2013-2026 Verileri
⚙️Variables:coumarin · piperazine · hybride molecules

Abstract

In this review, the effects of coumarin-piperazine hybrids on various biological targets are evaluated in light of current literature data (2013-2026). Coumarin-piperazine hybrids have been demonstrated to possess a wide range of pharmacological potential, including antibacterial, antimicrobial, antimalarial, antiviral, anticancer, antidiabetic, anti-Alzheimer's, and antitumor activities. In the context of the global health challenges posed by microbial resistance and neurodegenerative diseases, the high efficacy demonstrated by these hybrid molecules in preclinical studies is noteworthy. Furthermore, structure-activity relationship (SAR) studies indicate that the linker structure connecting the coumarin ring to the piperazine unit plays a decisive role in determining biological activity. Overall, coumarin-piperazine hybrids have emerged as one of the most notable hybrid systems in modern drug design due to their structural diversity and ability to interact with multiple biological targets. While studies reported in the literature demonstrate significant progress, particularly in applications targeting anticancer and neurodegenerative diseases, it is evident that areas such as tyrosinase inhibition, multitarget antibacterial antibacterial approaches, and translational pharmacology still hold considerable potential for further development.

🔖

Cite This Article

Özükanar, Ö. (2026). Coumarin-Piperazine Hybrids: An Investigation of Molecular Structure and Biological Activity (A Mini Review). EMU Journal of Pharmaceutical Sciences, Volume: 9 Issue: 2. https://doi.org/10.54994/emujpharmsci.1982637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (44)

  1. Annunziata F, Pinna C, Dallavalle S, Tamborini L, Pinto A (2020). An Overview of Coumarin as a Versatile and Readily Accessible Sca ff old with Broad-Ranging Biological Activities. International Journal of Molecular Sciences 29;21(13):4618.
  2. Auwal M, Ravichandran M, Pattabhiraman L, Kumar N (2026). Bioorganic Chemistry Coumarin-derived oxadiazoles as potential antiviral agents against coronaviruses. Bioorganic Chemistry 180: 110153.
  3. Buran K, Reis R, Sipahi H, Onen FE (2021). Piperazine and piperidine ‐ substituted 7 ‐ hydroxy coumarins for the development of anti ‐ inflammatory agents. Archiv der Pharmazie.
  4. Carneiro A, Barreiro S, Machado CS, Pinto M, Chavarria D, et al. (2026). Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem 1–17.
  5. Chandra KM, Goud NS, Arifuddin M, Alvala M, Alvala R, et al. (2021). Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors. Bioorganic and Medicinal Chemistry Letters 39.
  6. Chen Y, Wang S, Xu X, Liu X, Yu M, et al. (2013). Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics. J Med Chem 56: 4671−4690.
  7. Faizan MD, Kumar R, Mazumder A et al. (2024). The medicinal chemistry of piperazines: A review. Chemical Biology & Drug Design 1–23.
  8. Feng D, Zhang A, Yang Y, Yang P (2020). Coumarin-containing hybrids and their antibacterial activities. Archiv der Pharmazie 353: 1–12.
  9. Gangadhar KH, Benarjee V, Ratnamala A (2023). Coumarin-Piperazine Tethered 1,2,3-Triazoles: EGFR Targeting Anti-Breast Cancer Evaluation and Molecular Docking Studies. Polycyclic Aromatic Compounds 44, 5487–5503.
  10. Ghouse Mahammad S, Bahatam K, Angeli A, Pawar G, Chinchilli Kartheek K, et al. (2023). Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 38.
  11. Han G, Gu B, Young S, Som D, Mi S, et al. (2025). Biomedicine & Pharmacotherapy Topical administration of coumarin derivatives alleviates skin inflammatory symptoms in atopic dermatitis model. Biomedicine & Pharmacotherapy 186: 118004.
  12. Jaggal A, Katagi KS, Akki M, Babagond V, Kamat V, et al. (2025). A click-chemistry based strategy for synthesizing coumarin piperazine analogues: Assessment of anti-tubercular, anti-cancer, anti-inflammatory and antioxidant potentials. Journal of Molecular Structure 1320: 139388.
  13. Koley M, Han J, Soloshonok VA, Mojumder S, Javahershenas R, et al. (2024). Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies. RSC Medicinal Chemistry 10–54.
  14. Kuldeep S, Syed S, Hasan M, Sharma R, Singh K, et al. (2025). Design, synthesis, and biological evaluation of coumarin derivatives against tuberculosis: a pharmacophore ‑ based approach. Molecular Diversity.
  15. Mahdi M, Ashtiani A, Karimian S, Iraji A, Dastyafteh N (2026). Development of new coumarin-piperazine- N -phenylacetamid derivatives as potent tyrosinase inhibitors: In vitro and in silico evaluations. Medicinal Chemistry Research.
  16. Onder FC, Durdagi S, Sahin K, Ozpolat B, Ay M (2020). Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors. Journal of Chemical Information and Modelling.
  17. Ostrowska K, Le A, Czarnocka Z, Chmiel J, Bujalska-zadro M (2021). Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT 1A Serotonin Receptor Antagonists. Pharmaceuticals 14: 1–28.
  18. Pandhurnekar CP, Pandhurnekar HC, Arvind J, Edapu HK, Pagadala R, et al. (2026). Green Chemistry Letters and Reviews Recent advances in green and traditional synthetic approaches for coumarin derivatives: a comprehensive review. Green Chemistry Letters and Reviews 8253.
  19. Patel KB, Mukherjee S, Bhatt H, Rajani D, Ahmad I, et al. (2023). Synthesis, docking, and biological investigations of new coumarin-piperazine hybrids as potential antibacterial and anticancer agents. Journal of Molecular Structure 1276: 134755.
  20. Phutdhawong W, Chuenchid A, Taechowisan T, Sirirak J, Phutdhawong WS (2021). Synthesis and Biological Activity Evaluation of Coumarin-3-. Molecule 10–21.
  21. Sanad SMH, Mekky AEM (2022). Ultrasound-Mediated Synthesis of New ( Piperazine- Chromene ) -Linked Bis ( thieno [ 2, 3- b ] pyridine ) Hybrids as Potential Anti-acetylcholinesterase. Chemistry Select 202203020: 1–10.
  22. Santu A, Manoj E (2025). Coumarin based Schiff base proligands as promising antioxidant, antibacterial and anticancer agents: DFT and molecular docking correlations. Journal of Molecular Structure 1333: 141650.
  23. Sethi A, Kumar J, Vemula D, Gadde D, Talla V, et al. (2024). Sugar mimics and their probable binding sites: design and synthesis of thiazole linked coumarin- piperazine hybrids as galectin-1 inhibitors. RSC Advances 36794–36803.
  24. Shaveta, Mishra S, Singh P (2016). Hybrid molecules: The privileged scaffolds for various pharmaceuticals. European Journal of Medicinal Chemistry 124: 500–536.
  25. Shukur KT, Ercetin T, Luise C, Sippl W, Sirkecioglu O, et al. (2021). Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer’s disease. Archiv der Pharmazie 354.
  26. Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A (2018). ‘Coumarin: A natural, privileged and versatile scaffold for bioactive compounds’.
  27. Wang X, Zhou H, Wang X, Lei K, Wang S (2021). Design, Synthesis, and In Vivo and In Silico Evaluation of Coumarin Derivatives with Potential Antidepressant Effects. Molecules 26.
  28. Wilinski P, Kurzatkowski A, Ostrowska K (2025). Coumarin – Dithiocarbamate Derivatives as Biological Agents. Intermolecular Journal of Molecular Science 26: 1–15.
  29. Xiao J, Sun Z, Kong F, Gao F (2020). Current scenario of ferrocene-containing hybrids for antimalarial activity. European Journal of Medicinal Chemistry 185: 111791.
  30. Zala AR, Kumari P (2023). Synthesis, molecular docking, ADME study, and antimicrobial potency of piperazine based cinnamic acid bearing coumarin moieties as a DNA gyrase inhibitor General chemistry. J Biochem Mol Toxicol 1–11.
  31. Zeng C, Avula SR, Meng J, Zhou C (2023). Synthesis and Biological Evaluation of Piperazine Hybridized Coumarin Indolylcyanoenones with Antibacterial Potential. Molecules 28.
  32. Zhang R, Guo H, Deng H, Li J, Quan Z (2021). Piperazine skeleton in the structural modification of natural products: a review. Journal of Enzyme Inhibition and Medicinal Chemistry 36: 1165–1197.
  33. Carneiro A, Barreiro S, Machado CS, Pinto M, Chavarria D, et al. (2026). Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem 1–17.
  34. Faizan MD, Kumar R, Mazumder A et al. (2024). The medicinal chemistry of piperazines: A review. Chemical Biology & Drug Design 1–23.
  35. Jaggal A, Katagi KS, Akki M, Babagond V, Kamat V, et al. (2025). A click-chemistry based strategy for synthesizing coumarin piperazine analogues: Assessment of anti-tubercular, anti-cancer, anti-inflammatory and antioxidant potentials. Journal of Molecular Structure 1320: 139388.
  36. Kuldeep S, Syed S, Hasan M, Sharma R, Singh K, et al. (2025). Design, synthesis, and biological evaluation of coumarin derivatives against tuberculosis: a pharmacophore ‑ based approach. Molecular Diversity.
  37. Mahdi M, Ashtiani A, Karimian S, Iraji A, Dastyafteh N (2026). Development of new coumarin-piperazine- N -phenylacetamid derivatives as potent tyrosinase inhibitors: In vitro and in silico evaluations. Medicinal Chemistry Research.
  38. Ostrowska K, Le A, Czarnocka Z, Chmiel J, Bujalska-zadro M (2021). Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT 1A Serotonin Receptor Antagonists. Pharmaceuticals 14: 1–28.
  39. Pandhurnekar CP, Pandhurnekar HC, Arvind J, Edapu HK, Pagadala R, et al. (2026). Green Chemistry Letters and Reviews Recent advances in green and traditional synthetic approaches for coumarin derivatives: a comprehensive review. Green Chemistry Letters and Reviews 8253.
  40. Patel KB, Mukherjee S, Bhatt H, Rajani D, Ahmad I, et al. (2023). Synthesis, docking, and biological investigations of new coumarin-piperazine hybrids as potential antibacterial and anticancer agents. Journal of Molecular Structure 1276: 134755.
  41. Sanad SMH, Mekky AEM (2022). Ultrasound-Mediated Synthesis of New ( Piperazine- Chromene ) -Linked Bis ( thieno [ 2, 3- b ] pyridine ) Hybrids as Potential Anti-acetylcholinesterase. Chemistry Select 202203020: 1–10.
  42. Santu A, Manoj E (2025). Coumarin based Schiff base proligands as promising antioxidant, antibacterial and anticancer agents: DFT and molecular docking correlations. Journal of Molecular Structure 1333: 141650.
  43. Zala AR, Kumari P (2023). Synthesis, molecular docking, ADME study, and antimicrobial potency of piperazine based cinnamic acid bearing coumarin moieties as a DNA gyrase inhibitor General chemistry. J Biochem Mol Toxicol 1–11.
  44. Zhang R, Guo H, Deng H, Li J, Quan Z (2021). Piperazine skeleton in the structural modification of natural products: a review. Journal of Enzyme Inhibition and Medicinal Chemistry 36: 1165–1197.